Robbins Andrew R 4
4 · Cogent Biosciences, Inc. · Filed Jan 27, 2025
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-23+915,000→ 915,000 totalExercise: $8.89Exp: 2035-01-23→ Common Stock (915,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.